✉ info@591daili.com☎ +86-18553102138
📞 WhatsApp中文
Home › Product Catalog › Alectinib hydrochloride

Alectinib hydrochloride

CAS 1256589-74-8C30H34N4O2MW 482.6

Alectinib hydrochloride (CAS 1256589-74-8) — formula C30H34N4O2, molecular weight 482.6.

Product Overview

CAS Number1256589-74-8
Molecular FormulaC30H34N4O2
Molecular Weight482.6
LogP5.2

Technical Profile

What this product is

Alectinib hydrochloride is a chemical compound with CAS registry number 1256589-74-8 and molecular formula C30H34N4O2 (molecular weight 482.6).

Identification

CAS number: 1256589-74-8

Its molecular formula C30H34N4O2 comprises 30 C, 34 H, 4 N, 2 O atoms.

Also known as: Alectinib hydrochloride · 盐酸艾乐替尼

Frequently Asked Questions

What is the CAS number of Alectinib hydrochloride?

The CAS registry number of Alectinib hydrochloride is 1256589-74-8.

What is the molecular formula and molecular weight of Alectinib hydrochloride?

Molecular formula C30H34N4O2, molecular weight 482.6.

What other names is Alectinib hydrochloride known by?

It is also registered under: Alectinib hydrochloride, 盐酸艾乐替尼.

PubChem Public Data

Independent reference data for Alectinib hydrochloride (CAS 1256589-74-8), compiled from public chemistry databases.

Registry identifiers across databases

CAS Registry Number1256589-74-8
PubChem CID49806720
Molecular formulaC30H34N4O2
IUPAC name9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5H-benzo[b]carbazole-3-carbonitrile
UNII (FDA)LIJ4CT1Z3Y

Computed descriptors

Molecular Weight482.6
XLogP35.2
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count3
Exact Mass482.26817634
Monoisotopic Mass482.26817634
Topological Polar Surface Area72.4
Heavy Atom Count36

Physicochemical values on record

Dissociation Constants7.05

Documented uses on record

    Alectinib is indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC). It is also indicated as an adjuvant treatment in adult patients following tumor resection of ALK-positive non-small cell lung cancer.Alectinib is a tyrosine kinase receptor inhibitor and antineoplastic agent used in the therapy of selected forms of non-small cell lung cancer. Alectinib is associated with a high rate of serum aminotransferase elevations during therapy and with rare instances of clinically apparent acute liver injury.

    Synonyms and trade names

    Alectinib; 1256580-46-7; CH5424802; CH 5424802; AF-802; RO5424802; CH-5424802; AF802; 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5H-benzo[b]carbazole-3-carbonitrile; AF 802; LIJ4CT1Z3Y; RO-5424802; CHEBI:90936; DTXSID50154840; RG7853; 9-ETHYL-6,6-DIMETHYL-8-[4-(MORPHOLIN-4-YL)PIPERIDIN-1-YL]-11-OXO-5H,6H,11H-BENZO[B]CARBAZOLE-3-CARBONITRILE

    Regulatory listings held on file

    GHS notification summary66.7% (2 / 3)

    GHS hazard classification

    GHS notification summary66.7% (2 / 3)
    Reported hazard statementsH341 (33.3%), H361 (33.3%), H373 (33.3%)

    This chemical does not meet GHS hazard criteria for 66.7% (2 of 3) of all reports.

    H341 (33.3%): Suspected of causing genetic defects [Warning Germ cell mutagenicity]

    What the public record says

    Alectinib hydrochloride · CAS 1256589-74-8 · C30H34N4O2. UNII LIJ4CT1Z3Y. Dissociation Constants: 7.05.

    Source: PubChem / Wikidata; the batch COA governs where values differ.

Request a Quote

✉ info@591daili.com☎ +86-18553102138📞 WhatsAppEmail InquiryWhatsApp Inquiry

Supplier: Jinan Shenghe Chemical Co., Ltd.

中文页面: 盐酸艾乐替尼

鲁ICP备19031700号-2